Moderna Clinical Trials

Clinical trials sponsored by Moderna — phases, conditions and reported results. Data from ClinicalTrials.gov.

• A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participa
  Phase 1/2 · Lyme Disease · Completed · Jul 30, 2026
• COVID19 OutcomeS in Myeloma and the Impact of VaCcines
  N/A · Multiple Myeloma · Completed · May 18, 2026
• A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to
  Phase 1/2 · Genital Herpes · Completed · May 8, 2026
• Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 in Hea
  Phase 2 · Cytomegalovirus Infection · Completed · May 5, 2026
• A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent C
  Phase 3 · COVID-19 · Completed · May 1, 2026
• A Study to Investigate Cardiac Troponin Levels After mRNA-1273.712 Vaccine in Participants 12 Through 30 Years
  Phase 4 · Healthy Volunteers · Completed · Feb 4, 2026
• A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age
  Phase 3 · Respiratory Syncytial Virus · Completed · Dec 30, 2025
• A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults
  Phase 1/2 · SARS-CoV-2 · Completed · Dec 23, 2025
• Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273.214 SARS-CoV-2 (COVID-19) Vaccine
  Phase 2 · SARS-CoV-2 · Terminated · Nov 26, 2025
• Dose Escalation, Open-Label Clinical Trial to Evaluate Safety, Tolerability and Immunogenicity of a Nipah Viru
  Phase 1 · Nipah Virus Infection · Completed · Oct 23, 2025
• A Study of Zika Vaccine mRNA-1893 in Adult Participants Living in Endemic and Non-Endemic Flavivirus Areas
  Phase 2 · Zika Virus · Completed · Sep 25, 2025
• A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <1
  Phase 2/3 · SARS-CoV-2 · Completed · Sep 15, 2025
• A Study to Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Vir
  Phase 3 · Respiratory Syncytial Virus · Completed · Jul 30, 2025
• A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Vaccine Boosters
  Phase 2 · SARS-CoV-2 · Completed · Jul 17, 2025
• Study of mRNA-1010 Seasonal Influenza Vaccine in Adults
  Phase 3 · Seasonal Influenza · Completed · Jul 10, 2025

Trials by company

PfizerMerck (MSD)RocheNovartisAstraZenecaJohnson & Johnson (Janssen)Bristol Myers SquibbSanofiGSKEli LillyAbbVieAmgenBayerBoehringer IngelheimNovo NordiskTakedaGilead SciencesModernaBioNTechRegeneronVertexBiogenDaiichi SankyoAstellas PharmaEisaiOtsukaServierIncyteCelltrionSamsung BioepisHanmi PharmaceuticalYuhan

All trials